The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Psychiatry
(Dec 2020)
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
Nemanja N. Muric,
Nemanja N. Muric,
Nebojsa N. Arsenijevic,
Milica M. Borovcanin,
Milica M. Borovcanin
Affiliations
Nemanja N. Muric
Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
Nemanja N. Muric
Psychiatric Clinic, Clinical Center Kragujevac, Kragujevac, Serbia
Nebojsa N. Arsenijevic
Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
Milica M. Borovcanin
Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
Milica M. Borovcanin
Psychiatric Clinic, Clinical Center Kragujevac, Kragujevac, Serbia
DOI
https://doi.org/10.3389/fpsyt.2020.612347
Journal volume & issue
Vol. 11
Abstract
Read online
No abstracts available.
Keywords
chlorpromazine
SARS-CoV-2
COVID-19
psychosis
infection
WeChat QR code
Close